Organism 47977 - Aspergillus species (HYPHOMYCETES)

Organisms in NAP refer to specimens, they are not "taxonomical" organisms and they can in some cases even be mixtures of organisms. Empty organisms are used as placeholders as the original dataset entry system used organism as the central part.

Search for all experiments on this taxon

Organism Details

Property	Value
Taxon	8327
Family	HYPHOMYCETES
Genus	ASPERGILLUS
Species	SPECIES
Species authority
Subspecies
Subspecies authority
Comment
Citation	MIZOUE,K: OKAZAKI,T: HANADA,K: OMURA,S: AMAMOTO,T:. (1989). TRIPEPTIDE COMPOUND FROM ASPERGILLUS WHICH EXHIBIT ANTITUMOR ACTIVITY.. ()
Geographical area	EASTERN ASIA
Country	JAPAN

Experiments

6 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
112052	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR		Aspergillus species (HYPHOMYCETES)	ASPERGILLUS ANTIBIOTIC 1656-B
112053	PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Aspergillus species (HYPHOMYCETES)	ASPERGILLUS ANTIBIOTIC 1656-B
112054	PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	CATHEPSIN B INHIBITION	Aspergillus species (HYPHOMYCETES)	ASPERGILLUS ANTIBIOTIC 1656-B
112055	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR		Aspergillus species (HYPHOMYCETES)	ASPERGILLUS ANTIBIOTIC 1656-C
112056	PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Aspergillus species (HYPHOMYCETES)	ASPERGILLUS ANTIBIOTIC 1656-C
112057	PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED	CATHEPSIN B INHIBITION	Aspergillus species (HYPHOMYCETES)	ASPERGILLUS ANTIBIOTIC 1656-C

Show SPARQL Queries (1)